Reply to the letter regarding the article 'Sodium-glucose cotransporter 2 inhibitors influence skeletal muscle pathology in patients with heart failure and reduced ejection fraction'.
作者信息
Wood Nathanael, Witte Klaus K, Bowen T Scott
机构信息
School of Biomedical Sciences, Faculty of Biological Sciences, University of Leeds, Leeds, UK.
Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, UK.
出版信息
Eur J Heart Fail. 2024 Nov;26(11):2474-2475. doi: 10.1002/ejhf.3442. Epub 2024 Sep 18.
Abstract
摘要
相似文献
1
Reply to the letter regarding the article 'Sodium-glucose cotransporter 2 inhibitors influence skeletal muscle pathology in patients with heart failure and reduced ejection fraction'.关于文章《钠-葡萄糖协同转运蛋白2抑制剂对射血分数降低的心力衰竭患者骨骼肌病理的影响》的信件回复
Eur J Heart Fail. 2024 Nov;26(11):2474-2475. doi: 10.1002/ejhf.3442. Epub 2024 Sep 18.
2
Letter regarding the article 'Sodium-glucose cotransporter 2 inhibitors influence skeletal muscle pathology in patients with heart failure and reduced ejection fraction'.
Eur J Heart Fail. 2024 Nov;26(11):2474. doi: 10.1002/ejhf.3441. Epub 2024 Sep 18.
3
Potential of Sodium-Glucose Cotransporter-2 Inhibitors in the Management of Heart Failure With Preserved Ejection Fraction: A Narrative Review.钠-葡萄糖协同转运蛋白2抑制剂在射血分数保留的心力衰竭管理中的潜力：一项叙述性综述
Cureus. 2024 Nov 18;16(11):e73906. doi: 10.7759/cureus.73906. eCollection 2024 Nov.
4
The gap between real-world and guidelines in the use of sodium-glucose cotransporter 2 inhibitors for heart failure patients with reduced ejection fraction: Is it underestimated or overestimated? Letter regarding the article 'Real-world use of sodium-glucose cotransporter 2 inhibitors in patients with heart failure and reduced ejection fraction: Data from the Swedish Heart Failure Registry'.
Eur J Heart Fail. 2024 Mar;26(3):704-705. doi: 10.1002/ejhf.3163. Epub 2024 Feb 8.
5
Sodium-glucose cotransporter 2 inhibitors influence skeletal muscle pathology in patients with heart failure and reduced ejection fraction.钠-葡萄糖协同转运蛋白2抑制剂对射血分数降低的心力衰竭患者骨骼肌病理有影响。
Eur J Heart Fail. 2024 Apr;26(4):925-935. doi: 10.1002/ejhf.3192. Epub 2024 Mar 11.
6
Efficacy of Sodium-Glucose Cotransporter 2 Inhibitors in Heart Failure with a Preserved Ejection Fraction: A Meta-Analysis of Randomized Controlled Trials.钠-葡萄糖协同转运蛋白2抑制剂在射血分数保留的心力衰竭中的疗效：一项随机对照试验的荟萃分析。
Rev Cardiovasc Med. 2022 Oct 31;23(11):374. doi: 10.31083/j.rcm2311374. eCollection 2022 Nov.
7
Effects of sodium-glucose cotransporter-2 inhibitors on nutritional status in heart failure with reduced ejection fraction.钠-葡萄糖共转运蛋白 2 抑制剂对射血分数降低的心力衰竭患者营养状况的影响。
Rev Assoc Med Bras (1992). 2022 Nov 28;68(11):1576-1581. doi: 10.1590/1806-9282.20220737. eCollection 2022.
8
Reply to the letter regarding the article 'Changes in 6-min walk test is an independent predictor of death in chronic heart failure with reduced ejection fraction'.
Eur J Heart Fail. 2024 Oct;26(10):2299-2300. doi: 10.1002/ejhf.3448. Epub 2024 Sep 2.
9
A Review of Sodium-Glucose Cotransporter 2 Inhibitor's Clinical Efficacy in Heart Failure With Preserved Ejection Fraction.钠-葡萄糖协同转运蛋白2抑制剂在射血分数保留的心力衰竭中的临床疗效综述
Cureus. 2024 Apr 1;16(4):e57380. doi: 10.7759/cureus.57380. eCollection 2024 Apr.
10
Egyptian expert opinion for the use of sodium-glucose cotransporter-2 inhibitors in patients with heart failure with reduced ejection fraction.埃及专家关于钠-葡萄糖共转运蛋白 2 抑制剂在射血分数降低的心力衰竭患者中的应用的意见。
ESC Heart Fail. 2022 Apr;9(2):800-811. doi: 10.1002/ehf2.13811. Epub 2022 Feb 3.
本文引用的文献
1
Sodium-glucose cotransporter 2 inhibitors influence skeletal muscle pathology in patients with heart failure and reduced ejection fraction.钠-葡萄糖协同转运蛋白2抑制剂对射血分数降低的心力衰竭患者骨骼肌病理有影响。
Eur J Heart Fail. 2024 Apr;26(4):925-935. doi: 10.1002/ejhf.3192. Epub 2024 Mar 11.
2
Sodium-glucose co-transporter 2 inhibitors and Sarcopenia: A controversy that must be solved.钠-葡萄糖协同转运蛋白2抑制剂与肌肉减少症：一个必须解决的争议。
Clin Nutr. 2023 Dec;42(12):2338-2352. doi: 10.1016/j.clnu.2023.10.004. Epub 2023 Oct 5.
Zotero 插件